13:27 IST
NSE
Management Change
Par Drugs & Chemicals Management Change
Par Drugs re-appointed its statutory auditor and executive director/CEO. These appointments were approved at the company's 27th Annual General Meeting.
Par Drugs & Chemicals Ltd
- Share price
- ₹125.28
- Market cap
- ₹154.2 Cr
- Revenue (annual)
- ₹103.7 Cr
- Net profit (annual)
- ₹13.11 Cr
- P/E (TTM)
- 10.6×Sector 47.3×
- Promoter holding
- 73.41%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Legal & Regulatory 4Financial Results 4Other Announcement 2Management Change 2Annual General Meeting 2Board Meeting Outcome 1Board Meeting Date 1
Time
2 announcements with these filters
18:39 IST
NSE
Management Change
Par Drugs & Chemicals Management Change
Par Drugs and Chemicals Limited has re-appointed M/s. Siddhpura & Co. as Internal Auditor and M/s. Maulin Shah & Associates as Cost Auditor.